Stratec SE Share Price
Stocks
SBS
DE000STRA555
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.54 EUR | -2.30% |
|
+2.84% | -12.96% |
| 15/07 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reaffirms its Neutral rating | ZD |
| 03/07 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg gives a Buy rating | ZD |
| Market Cap | 24Cr 27Cr 22Cr 20Cr 38Cr 2.62TCr 39Cr 261.98Cr 103.04Cr 1.28TCr 102.07Cr 100Cr 4.41TCr | P/E 2026 * |
19x | P/E 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise Value | 34Cr 39Cr 31Cr 29Cr 54Cr 3.73TCr 55Cr 372.93Cr 146.68Cr 1.82TCr 145.3Cr 142.12Cr 6.28TCr | EV / Sales 2026 * |
1.27x | EV / Sales 2027 * | 1.18x |
| Free-Float |
39.72% | Yield 2026 * |
3.43% | Yield 2027 * | 3.95% |
Last Transcript: Stratec SE
| 1 day | -2.30% | ||
| 1 week | +2.84% | ||
| Current month | +16.31% | ||
| 1 month | +7.24% | ||
| 3 months | -1.51% | ||
| 6 months | -18.07% | ||
| Current year | -12.96% |
| 1 week | 18.28 |  | 20.15 |
| 1 month | 16.7 | | 20.15 |
| Current year | 16.3 | | 24.5 |
| 1 year | 16.3 | | 33.1 |
| 3 years | 16.3 | | 52.4 |
| 5 years | 16.3 | | 147.4 |
| 10 years | 16.3 | | 147.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 59 | 01/04/2011 |
Tanja Bücherl
DFI | Director of Finance/CFO | 38 | 01/11/2025 |
Sandra Dittus
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Hiller
CHM | Chairman | 60 | 29/05/2019 |
Rolf Vornhagen
BRD | Director/Board Member | 73 | 21/07/2020 |
Georg Heni
CHM | Chairman | 68 | 20/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/03/23 | Buy | Chief Executive Officer | 150 | 0.0012% | ||
| 15/03/23 | Buy | Chief Executive Officer | 145 | 0.0012% | ||
| 13/03/23 | Buy | Chief Executive Officer | 220 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.30% | +2.84% | -31.92% | -68.12% | 27Cr | |
| -1.97% | +1.03% | +28.39% | +1.68% | 20TCr | |
| -0.58% | +2.40% | +7.25% | -15.35% | 14TCr | |
| -14.15% | -15.08% | -33.40% | -2.68% | 12TCr | |
| -1.32% | -1.65% | -57.52% | -16.63% | 6.54TCr | |
| -2.40% | -7.03% | +12.08% | -6.81% | 4.94TCr | |
| -0.11% | +1.53% | -23.83% | -30.51% | 4.47TCr | |
| -3.41% | -2.11% | +15.33% | +9.95% | 3.71TCr | |
| -2.44% | -1.98% | +28.33% | +35.71% | 3.62TCr | |
| -1.86% | -2.39% | -22.85% | -10.01% | 2.87TCr | |
| Average | -3.05% | -1.80% | -7.81% | -10.28% | 7.26TCr | |
| Weighted average by Cap. | -3.69% | -1.84% | -1.00% | -5.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27Cr 31Cr 25Cr 23Cr 43Cr 2.94TCr 44Cr 294.63Cr 115.88Cr 1.44TCr 114.8Cr 112.28Cr 4.96TCr | 28Cr 32Cr 26Cr 24Cr 46Cr 3.13TCr 47Cr 313.09Cr 123.15Cr 1.53TCr 121.99Cr 119.31Cr 5.27TCr |
| Net income | 1.4Cr 1.6Cr 1.29Cr 1.19Cr 2.25Cr 154.52Cr 2.3Cr 15Cr 6.08Cr 76Cr 6.03Cr 5.89Cr 260.53Cr | 1.83Cr 2.09Cr 1.69Cr 1.56Cr 2.93Cr 201.5Cr 3Cr 20Cr 7.93Cr 99Cr 7.86Cr 7.69Cr 339.73Cr |
| Net Debt | 10Cr 12Cr 9.28Cr 8.56Cr 16Cr 1.11TCr 16Cr 110.95Cr 44Cr 542.91Cr 43Cr 42Cr 1.87TCr | 9.77Cr 11Cr 9.02Cr 8.31Cr 16Cr 1.08TCr 16Cr 107.76Cr 42Cr 527.28Cr 42Cr 41Cr 1.82TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | €19.54 | -2.30% | 9,601 |
| 16/26/16 | €20.00 | +1.32% | 21,629 |
| 15/26/15 | €19.74 | +3.89% | 9,458 |
| 14/26/14 | €19.00 | -1.04% | 4,920 |
| 13/26/13 | €19.20 | +1.05% | 8,428 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SBS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
